Jana de Boniface

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Var god se den engelska sidan för mer information.
Please switch to the English page for more information.

Artiklar

Journal article: RADIOTHERAPY AND ONCOLOGY. 2024;197:110372

Quality assessment of radiotherapy in the prospective randomized SENOMAC trial.

Alkner S; Wieslander E; Lundstedt D; Berg M; Kristensen I; Andersson Y; Bergkvist L; Frisell J; Olofsson Bagge R; Sund M; Christiansen P; Davide Gentilini O; Kontos M; Kühn T; Reimer T; Rydén L; Filtenborg Tvedskov T; Vrou Offersen B; Dahl Nissen H; de Boniface J; SENOMAC Trialists’ Group
Journal article: SENOLOGIE - ZEITSCHRIFT FÜR MAMMADIAGNOSTIK UND -THERAPIE. 2024;21(02):e2-e3

Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

Banys-Paluchowski M; Basali T; Hartmann S; de Boniface J; Gentilini OD; Stickeler E; Untch M; Ruf F; Fröhlich S; Gasparri ML; Thill M; Lux MP; Peintinger F; Cakmak GK; Rubio IT; Kontos M; Di Micco R; Murawa D; Schlichting E; Sezen BA; Rody A; Langanke D; Mendez JIS; Bjelic-Radisic V; Solbach C; Ovalle SC; Mau C; Buchmann N; Riemer S; Hansen MH; Bauer L; Schnabel J; Von Abel E; Ditsch N; Kühn T
Journal article: SENOLOGIE - ZEITSCHRIFT FÜR MAMMADIAGNOSTIK UND -THERAPIE. 2024;21(02):e9-e10

Marking of target lymph nodes with clips/ coils in breast cancer patients undergoing neoadjuvant chemotherapy – first results from the AXSANA study (NCT04373655)

Fröhlich S; Hartmann S; Banys-Paluchowski M; Ditsch N; Thill M; Hahn M; Lux MP; de Boniface J; Gentilini OD; Stickeler E; Hauptmann M; Basali T; Berger T; Rief A; Ruf F; Schmidt EE; Wihlfahrt K; Sezen BA; Bonci E-A; Di Micco R; Dostalek L; Gaspari ML; Helidon N; Ivanov T; Kadayaprath G; Cakmak GK; Kontos M; Kothari A; Murawa D; Niinikoski L; Peintinger F; Perhavec A; Pinto D; Qanimat HV; Rebaza LP; Rubio IT; Schlichting E; Shaari E; Thongvitokomarn S; Vanhoeij M; Zippel D; Watermann D; Schrauder MG; Graßhoff S-T; Kühn T
Journal article: SENOLOGIE - ZEITSCHRIFT FÜR MAMMADIAGNOSTIK UND -THERAPIE. 2024;21(02):e27

Marking of Target Lymph Nodes with carbon suspension in breast cancer patients undergoing neoadjuvant chemotherapy – first results from the AXSANA study (NCT04373655)

Rief A; Hartmann S; Banys-Paluchowski M; de Boniface J; Gentlini OD; Stickeler E; Cakmak GK; Hauptmann M; Basali T; Berger T; Fröhlich S; Ruf F; Schmidt E; Wihlfahrt K; Sezen BA; Porpiglia M; Zetterlund L; Natsiopoulos I; Sackey H; Hadar T; Weigel M; Dostalek L; Iosifidou R; Schrauder MG; Kaltenecker G; Langanke D; Zippel D; Kühn T
Journal article: CANCER RESEARCH. 2024;84(9_Supplement):po3-23-03-po3-23-03

Abstract PO3-23-03: Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

Banys-Paluchowski M; Hartmann S; de Boniface J; Gentilini OD; Basali T; Stickeler E; Untch M; Ruf F; Fröhlich S; Thill M; Lux MP; Peintinger F; Cakmak GK; Rubio I; Kontos M; Micco RD; Murawa D; Schlichting E; Sezen BA; Rody A; Langanke D; Bündgen N; Sanchez-Mendez JI; Buss-Steidle R; Mau C; Buchmann N; Riemer S; Hansen MH; Ditsch N; Kühn T
Journal article: CANCER RESEARCH. 2024;84(9_Supplement):po4-19-04-po4-19-04

Abstract PO4-19-04: AXSANA – EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

Kühn T; Hartmann S; Stickeler E; de Boniface J; Gentilini OD; Fröhlich S; Ruf F; Thill M; Hauptmann M; Cakmak GK; Rubio I; Gasparri ML; Kontos M; Bonci E-A; Niinikoski L; Sezen BA; Micco RD; Murawa D; Kadayaprath G; Pinto D; Peintinger F; Appelgren M; Simons JM; Smidt M; Schlichting E; Dostalek L; Thiemann E; Hahn M; Schrauder M; Gunay S; Gurleyik G; Helidon N; Valiyeva H; Kothari A; Vanhoeij M; Perhavec A; Ivanov T; Zippel D; Rebaza L; Thongvitokomarn S; Loibl S; Banys-Paluchowski M
Journal article: CANCER RESEARCH. 2024;84(9_Supplement):po1-19-06-po1-19-06

Abstract PO1-19-06: Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: the randomized Neo-ACT trial

de Boniface J; Ringborg CH; Altena R; Wengström Y
Journal article: CANCER RESEARCH. 2024;84(9_Supplement):po5-19-02-po5-19-02

Abstract PO5-19-02: I-PREPARE: International Prospective REgistry on Pre-pectorAl breast Reconstruction (EUBREAST 11R-NCT 05817175)

Micco RD; Banys-Paluchowski M; Cardoso M-J; de Boniface J; Gulluoglu BM; Kaidar-Person O; Kühn T; Nava MB; Poortmans P; Potter S; Rotmensz N; Spanic T; Thill M; Travado L; Weber W; Gentilini OD
Journal article: CANCER RESEARCH. 2024;84(9_Supplement):po4-18-12-po4-18-12

Abstract PO4-18-12: MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET, NCT 05559411)

Banys-Paluchowski M; Kühn T; Masannat Y; Ditsch N; Esgueva A; Cabıoğlu N; Murawa D; Canturk NZ; Rubio I; de Boniface J; Karakatsanis A; Dave R; Potter S; Kothari A; Gentilini OD; Weber W; Krawczyk N; Hartmann S; Cakmak GK; Hahn M; Lux MP; Tvedskov T; Pankratjevaite L; Kontos M; Peintinger F; Lowery A; Smidt M; Rebaza L; Vasconcelos M; Gulluoglu BM; Sezen BA; Micco RD; Nietz S; Malherbe F; Gasparri ML; Alran S; Deo S; Khan MM; Harvey J
Journal article: CANCER RESEARCH. 2024;84(9_Supplement):po1-23-02-po1-23-02

Abstract PO1-23-02: Magnetic seeds used for the detection of target lymph nodes after neoadjuvant therapy for early breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial

Kolberg H-C; Hartmann S; Banys-Paluchowski M; Stickeler E; de Boniface J; Gentilini OD; Fröhlich S; Thill M; Lux MP; Cakmak GK; Rubio I; Kontos M; Micco RD; Murawa D; Kühn T
Journal article: CANCER RESEARCH. 2024;84(9_Supplement):gs02-06-gs02-06

Abstract GS02-06: Recurrence-free survival following sentinel node-positive breast cancer without completion axillary lymph node dissection – first results from the international randomized SENOMAC trial

de Boniface J; Tvedskov T; Leif B; Frisell J; Andersson Y; Alkner S; Sund M; Bagge RO; Lundstedt D; Gentilini OD; Kontos M; Reimer T; Offersen B; Kühn T; Rydén L; Christiansen P
Journal article: CANCER RESEARCH. 2024;84(9_Supplement):po1-19-03-po1-19-03

Abstract PO1-19-03: The T-REX trial: a randomized international non-inferiority trial on Tailored Regional EXternal beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases

Alkner S; de Boniface J; Lundstedt D; Mjaaland I; Rydén L; vikström J; Bendahl P-O; Holmberg E; Sackey H; Wieslander E; Karlsson P
Article: THE LANCET REGIONAL HEALTH - AMERICAS. 2024;33:100734

Which real indications remain for mastectomy?

Cardoso MJ; de Boniface J; Dodwell D; Kaidar-Person O; Poortmans P; van Maaren MC
Article: BMJ OPEN. 2024;14(4):e084488

Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project.

Potter S; Avery K; Ahmed R; de Boniface J; Chatterjee S; Dodwell D; Dubsky P; Iwata H; Jiang M; Lee H-B; MacKenzie M; Poulakaki F; Richardson AL; Sepulveda K; Spillane A; Thompson AM; Werutsky G; Wright JL; Zdenkowski N; Cowan K; McIntosh S
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2024;390(13):1163-1175

Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.

de Boniface J; Filtenborg Tvedskov T; Rydén L; Szulkin R; Reimer T; Kühn T; Kontos M; Gentilini OD; Olofsson Bagge R; Sund M; Lundstedt D; Appelgren M; Ahlgren J; Norenstedt S; Celebioglu F; Sackey H; Scheel Andersen I; Hoyer U; Nyman PF; Vikhe Patil E; Wieslander E; Dahl Nissen H; Alkner S; Andersson Y; Offersen BV; Bergkvist L; Frisell J; Christiansen P; SENOMAC Trialists’ Group; SENOMAC Trialists' Group
Journal article: EJSO. 2024;50(2):107446

Patients’ experiences of axillary surgery in the randomized SENOMAC trial: a focus group study

Appelgren M; Wengström Y; de Boniface J; Sackey H
Article: BJS OPEN. 2024;8(1):zrae003

National long-term patient-reported outcomes following mastectomy with or without breast reconstruction: The Swedish Breast Reconstruction Outcome Study Part 2 (SweBRO 2).

Gümüscü R; Unukovych D; Wärnberg F; de Boniface J; Sund M; Åhsberg K; Hansson E; Folkvaljon F; Mani M
Article: BREAST CARE. 2023;18(6):428-439

Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy.

Banys-Paluchowski M; Hartmann S; Ditsch N; Krawczyk N; Kühn T; de Boniface J; Banys-Kotomska J; Rody A; Krug D
Article: BREAST CANCER RESEARCH AND TREATMENT. 2023;202(3):497-504

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study.

Hartmann S; Banys-Paluchowski M; Stickeler E; de Boniface J; Gentilini OD; Kontos M; Seitz S; Kaltenecker G; Wärnberg F; Zetterlund LH; Kolberg H-C; Fröhlich S; Kühn T
Article: ANNALS OF ONCOLOGY. 2023;34(11):970-986

Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.

Curigliano G; Burstein HJ; Gnant M; Loibl S; Cameron D; Regan MM; Denkert C; Poortmans P; Weber WP; Thürlimann B; St Gallen Consensus Conference Panelists 2023
Article: BMJ OPEN. 2023;13(9):e075543

Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial.

Alkner S; de Boniface J; Lundstedt D; Mjaaland I; Ryden L; Vikstrom J; Bendahl P-O; Holmberg E; Sackey H; Wieslander E; Karlsson P
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_suppl):tps626

MELODY (Methods for Localization of Different Types of Breast Lesions): A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET).

Banys-Paluchowski M; Kühn T; Masannat Y; Rubio IT; de Boniface J; Ditsch N; Karakatsanis A; Dave RV; Potter S; Kothari A; Gentilini OD; Weber WP; Krawczyk N; Hartmann S; Karadeniz Cakmak G; Hahn M; Lux MP; Smidt M; Cabioglu N; Harvey J
Article: ARCHIVES OF GYNECOLOGY AND OBSTETRICS. 2023;307(5):1547-1556

Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey.

Banys-Paluchowski M; Untch M; Krawczyk N; Thurmann M; Kühn T; Sehouli J; Gasparri ML; de Boniface J; Gentilini OD; Stickeler E; Ditsch N; Rody A; Paluchowski P; Blohmer J-U
Article: LAKARTIDNINGEN. 2023;120:22149

En dos antibiotika lika effektiv vid bröstimplantatkirurgi.

Gahm J; de Boniface J; Frisell J
Journal article: BREAST. 2023;68:s7-s8

SA 7.2 Axillary surgery in the adjuvant setting

de Boniface J
Article: BRITISH JOURNAL OF SURGERY. 2023;110(3):344-352

Medical and surgical postoperative complications after breast conservation versus mastectomy in older women with breast cancer: Swedish population-based register study of 34 139 women.

de Boniface J; Szulkin R; Johansson ALV
Article: JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. 2023;76:18-26

Capsular inflammation after immediate breast reconstruction - Gene expression patterns and inflammatory cell infiltration in irradiated and non-irradiated breasts.

Frisell A; Bergman O; Khan A; Gisterå A; Fisher RM; Lagergren J; de Boniface J; Halle M
Article: BRITISH JOURNAL OF SURGERY. 2022;109(11):1107-1115

Long-term outcomes of implant-based immediate breast reconstruction with and without radiotherapy: a population-based study.

de Boniface J; Coudé Adam H; Frisell A; Oikonomou I; Ansarei D; Ljung Konstantinidou A; Liu Y; Abo Alniaj B; Wallmon P; Halle M; Johansson ALV; Sackey H
Article: BRITISH JOURNAL OF SURGERY. 2022;109(10):977-983

Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women.

de Boniface J; Szulkin R; Johansson ALV
Article: JAMA NETWORK OPEN. 2022;5(9):e2231583

Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction: A Randomized Clinical Trial.

Gahm J; Ljung Konstantinidou A; Lagergren J; Sandelin K; Glimåker M; Johansson H; Wickman M; de Boniface J; Frisell J
Article: BRITISH JOURNAL OF SURGERY. 2022;109(9):857-863

Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey.

Gasparri ML; de Boniface J; Poortmans P; Gentilini OD; Kaidar-Person O; Banys-Paluchowski M; Di Micco R; Niinikoski L; Murawa D; Bonci EA; Pasca A; Rubio IT; Karadeniz Cakmak G; Kontos M; Kühn T
Article: BREAST CANCER RESEARCH AND TREATMENT. 2022;193(3):589-595

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.

de Boniface J; Frisell J; Kühn T; Wiklander-Bråkenhielm I; Dembrower K; Nyman P; Zouzos A; Gerber B; Reimer T; Hartmann S
Article: BREAST. 2022;63:123-139

Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy.

Weber WP; Shaw J; Pusic A; Wyld L; Morrow M; King T; Mátrai Z; Heil J; Fitzal F; Potter S; Rubio IT; Cardoso M-J; Gentilini OD; Galimberti V; Sacchini V; Rutgers EJT; Benson J; Allweis TM; Haug M; Paulinelli RR; Kovacs T; Harder Y; Gulluoglu BM; Gonzalez E; Faridi A; Elder E; Dubsky P; Blohmer J-U; Bjelic-Radisic V; Barry M; Hay SD; Bowles K; French J; Reitsamer R; Koller R; Schrenk P; Kauer-Dorner D; Biazus J; Brenelli F; Letzkus J; Saccilotto R; Joukainen S; Kauhanen S; Karhunen-Enckell U; Hoffmann J; Kneser U; Kühn T; Kontos M; Tampaki EC; Carmon M; Hadar T; Catanuto G; Garcia-Etienne CA; Koppert L; Gouveia PF; Lagergren J; Svensjö T; Maggi N; Kappos EA; Schwab FD; Castrezana L; Steffens D; Krol J; Tausch C; Günthert A; Knauer M; Katapodi MC; Bucher S; Hauser N; Kurzeder C; Mucklow R; Tsoutsou PG; Sezer A; Çakmak GK; Karanlik H; Fairbrother P; Romics L; Montagna G; Urban C; Walker M; Formenti SC; Gruber G; Zimmermann F; Zwahlen DR; Kuemmel S; El-Tamer M; Vrancken Peeters MJ; Kaidar-Person O; Gnant M; Poortmans P; de Boniface J
Article: BREAST. 2022;63:16-23

Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial.

Appelgren M; Sackey H; Wengström Y; Johansson K; Ahlgren J; Andersson Y; Bergkvist L; Frisell J; Lundstedt D; Rydén L; Sund M; Alkner S; Vrou Offersen B; Filtenborg Tvedskov T; Christiansen P; de Boniface J; SENOMAC Trialists' Group
Journal article: TUMOR DIAGNOSTIK UND THERAPIE. 2022;43(03):197-203

Gezielte Entfernung axillärer Lymphknoten nach Kohlenstoffmarkierung bei Patientinnen mit primär systemisch behandeltem Mammakarzinom

Hartmann S; Stachs A; Kühn T; de Boniface J; Banys-Paluchowski M; Reimer T
Journal article: SENOLOGIE - ZEITSCHRIFT FÜR MAMMADIAGNOSTIK UND -THERAPIE. 2022;19(01):49-55

Gezielte Entfernung axillärer Lymphknoten nach Kohlenstoffmarkierung bei Patientinnen mit primär systemisch behandeltem Mammakarzinom

Hartmann S; Stachs A; Kühn T; de Boniface J; Banys-Paluchowski M; Reimer T
Article: ANNALS OF SURGICAL ONCOLOGY. 2022;29(2):1061-1070

Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.

Fitzal F; Bolliger M; Dunkler D; Geroldinger A; Gambone L; Heil J; Riedel F; de Boniface J; Andre C; Matrai Z; Pukancsik D; Paulinelli RR; Ostapenko V; Burneckis A; Ostapenko A; Ostapenko E; Meani F; Harder Y; Bonollo M; Alberti ASM; Tausch C; Papassotiropoulos B; Helfgott R; Heck D; Fehrer H-J; Acko M; Schrenk P; Trapp EK; Gunda P-T; Clara P; Montagna G; Ritter M; Blohmer J-U; Steffen S; Romics L; Morrow E; Lorenz K; Fehr M; Weber WP
Journal article: EJSO. 2022;48(2):e30

AXSANA: A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with NACT

Rubio IT; Banys-Paluchowski M; Hartmann S; Stickeler E; de Boniface J; Gentilini O; Pinto D; Di Micco R; Fröhlich S; Thill M; Hauptmann M; Cakmak GK; Gasparri ML; Kontos M; Bonci E-A; Niinikoski L; Murawa D; Peintinger F; Dostalek L; Kühn T
Article: PLOS ONE. 2022;17(10):e0274804

Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial.

de Boniface J; Altena R; Haddad Ringborg C; Bolam KA; Wengström Y
Article: BRITISH JOURNAL OF SURGERY. 2021;108(12):1474-1482

Effect of radiotherapy on expanders and permanent implants in immediate breast reconstruction: long-term surgical and patient-reported outcomes in a large multicentre cohort.

Coudé Adam H; Frisell A; Liu Y; Sackey H; Oikonomou I; Docherty Skogh A-C; Frisell J; de Boniface J
Article: BREAST. 2021;59:383-392

Survival in breast cancer patients with a delayed DIEP flap breast reconstruction after adjustment for socioeconomic status and comorbidity.

Coudé Adam H; Docherty Skogh AC; Edsander Nord Å; Schultz I; Gahm J; Hall P; Frisell J; Halle M; de Boniface J
Article: BRITISH JOURNAL OF SURGERY. 2021;108(9):1105-1111

Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.

Andersson Y; Bergkvist L; Frisell J; de Boniface J
Article: BMJ OPEN. 2021;11(9):e045239

Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trial.

Kappos EA; Schulz A; Regan MM; Moffa G; Harder Y; Ribi K; Potter S; Pusic AL; Fehr MK; Hemkens LG; Holzbach T; Farhadi J; Simonson C; Knauer M; Verstappen R; Bucher HC; Zwahlen D; Zimmermann F; Schwenkglenks M; Mucklow R; Shaw J; Bjelic-Radisic V; Chiorescu A; Chun YS; Farah S; Xiaosong C; Nigard L; Kuemmel S; Reitsamer R; Hauschild M; Fulco I; Tausch C; Fischer T; Sarlos D; Constantinescu MA; Lupatsch JE; Fitzal F; Heil J; Matrai Z; de Boniface J; Kurzeder C; Haug M; Weber WP
Journal article: RADIOTHERAPY AND ONCOLOGY. 2021;161:s42-s43

OC-0069 Quality assessment of locoregional breast cancer radiotherapy in the international SENOMACtrial

Alkner S; Lundstedt D; Wieslander E; Berg M; Kristensen I; Ahlgren J; Offersen B; de Boniface J; Nissen HD; O.B.O.T.S.T.G.
Article: JAMA SURGERY. 2021;156(7):628-637

Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: A Swedish National 6-Year Follow-up of 48 986 Women.

de Boniface J; Szulkin R; Johansson ALV
Article: BRITISH JOURNAL OF SURGERY. 2021;108(5):583-589

Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status.

Zetterlund L; Celebioglu F; Hatschek T; Frisell J; de Boniface J
Article: BRITISH JOURNAL OF SURGERY. 2021;108(3):302-307

Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial.

Hartmann S; Kühn T; de Boniface J; Stachs A; Winckelmann A; Frisell J; Wiklander-Bråkenhielm I; Stubert J; Gerber B; Reimer T
Journal article: BREAST. 2021;56:s69

P127 Survival after breast conservation versus mastectomy adjusted for comorbidity and socioeconomic status: national 6-year follow-up on 48986 women

de Boniface J; Szulkin R; Johansson A
Journal article: BREAST. 2021;56:s71-s72

P134 Retrospective multicenter analysis comparing conventional with oncoplastic breast conservation: oncologic and surgical outcome in women with high risk breast cancer from the OPBC-01/iTOP2 study

Fitzal F; Bolliger M; Dunkler D; Gambone L; Heil J; Riedel F; de Boniface J; André C; Matrai Z; Pukancsik D; Paulinelli RR; Ostapenko V; Burneckis A; Ostapenko A; Ostapenko E; Meani F; Harder Y; Bonollo M; Alberti ASM; Tausch C; Papassotiropoulos B; Helfgott R; Heck D; Fehrer HJ; Acko M; Schrenk P; Montagna G; Trapp E; Pristauz G; Paliczek C; Blohmer JU; Steffen S; Romics L; Morrow E; Lorenz K; Fehr M; Ritter M; Weber WP
Journal article: CANCER RESEARCH. 2021;81(4_Supplement):ot-23-03-ot-23-03

Abstract OT-23-03: Pre- versus sub-pectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02 PREPEC): A pragmatic, multicenter, randomized, superiority trial

Weber WP; Kappos EA; Regan MM; Moffa G; Harder Y; Ribi K; Potter S; Pusic A; Fehr MK; Hemkens LG; Holzbach T; Farhadi J; Simonson C; Knauer M; Verstappen R; Bucher H; Zwahlen D; Zimmermann F; Schwenkglenks M; Mucklow R; Bjelic-Radisic V; Chiorescu A; Chun Y; Farah S; Chen X; Nigard L; Kümmel S; Reitsamer R; Hauschild M; Fulco I; Tausch C; Fischer T; Sarlos D; Constantinescu M; Lupatsch JE; Fitzal F; Heil J; Mátrai Z; de Boniface J; Kurzeder C; Haug M; Schulz A
Journal article: CANCER RESEARCH. 2021;81(4_Supplement):ot-04-02-ot-04-02

Abstract OT-04-02: The AXSANA trial (AXillary Surgery After NeoAdjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Banys-Paluchowski M; Stickeler E; de Boniface J; Gentilini O; Thill M; Hartmann S; Mangold M; Solbach C; Blohmer J-U; Untch M; Appelgren M; Kolberg H-C; Kühn T
Article: BJS OPEN. 2021;5(1):zraa013

Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer.

André C; Holsti C; Svenner A; Sackey H; Oikonomou I; Appelgren M; Johansson ALV; de Boniface J
Journal article: BRITISH JOURNAL OF SURGERY. 2021;108(3):302-307

Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial

Hartmann S; Kuehn T; de Boniface J; Stachs A; Winckelmann A; Frisell J; Wiklander-Brakenhielm I; Stubert J; Gerber B; Reimer T
Article: BREAST CANCER RESEARCH AND TREATMENT. 2020;184(3):977-984

Risk factors for implant failure following revision surgery in breast cancer patients with a previous immediate implant-based breast reconstruction.

Frisell A; Lagergren J; Halle M; de Boniface J
Article: EJSO. 2020;46(10 Pt A):1867-1873

Breast reconstruction patterns from a Swedish nation-wide survey.

Unukovych D; Gümüscü R; Wärnberg F; de Boniface J; Eriksen C; Sund M; Nåsell P; Åhsberg K; Olofsson P; Lewin R; Lambe M; Brandberg Y; Folkvaljon F; Mani M
Journal article: EUROPEAN JOURNAL OF CANCER. 2020;138:s3

1B Oral Omitting completion axillary lymph node dissection after sentinel node micrometastases in breast cancer – first results from the Swedish prospective SENOMIC trial

Andersson Y; Bergkvist L; Frisell J; de Boniface J
Journal article: EUROPEAN JOURNAL OF CANCER. 2020;138:s36

159 Poster Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer

Andersson Y; Frisell J; Bergkvist L; de Boniface J
Journal article: EUROPEAN JOURNAL OF CANCER. 2020;138:s95

375 Poster Breast cancer patients undergoing delayed deep inferior epigastric perforator (DIEP) flap reconstruction differ from their matched controls by a higher socioeconomic status and better overall survival

Adam H; Skogh ACD; Frisell J; De Boniface J
Journal article: EUROPEAN JOURNAL OF CANCER. 2020;138:s22

111 Poster Long-term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

Zetterlund L; Celebioglu F; Frisell J; de Boniface J
Journal article: EUROPEAN JOURNAL OF CANCER. 2020;138:s3

1A Oral The generalisability of randomised clinical trials: An interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer

De Boniface J; Ahlgren J; Andersson Y; Bergkvist L; Frisell J; Lundstedt D; Bagge RO; Rydén L; Sund M; Group ST
Journal article: EUROPEAN JOURNAL OF CANCER. 2020;138:s28-s29

134 Poster Oncoplastic breast-conserving surgery offers low local recurrence rates and excellent survival rates despite worse tumor characteristics

André C; Holsti C; Svenner A; Oikonomou I; Sackey HI; Appelgren M; Johansson A; de Boniface J
Article: BJS OPEN. 2020;4(2):232-240

Influence of socioeconomic status on immediate breast reconstruction rate, patient information and involvement in surgical decision-making.

Frisell A; Lagergren J; Halle M; de Boniface J
Article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(3):1185-1198

CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment.

Neo SY; Yang Y; Record J; Ma R; Chen X; Chen Z; Tobin NP; Blake E; Seitz C; Thomas R; Wagner AK; Andersson J; de Boniface J; Bergh J; Murray S; Alici E; Childs R; Johansson M; Westerberg LS; Haglund F; Hartman J; Lundqvist A
Article: BREAST CANCER RESEARCH AND TREATMENT. 2020;179(3):721-729

Socioeconomic status differs between breast cancer patients treated with mastectomy and breast conservation, and affects patient-reported preoperative information.

Frisell A; Lagergren J; Halle M; de Boniface J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2020;180(1):167-176

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.

de Boniface J; Ahlgren J; Andersson Y; Bergkvist L; Frisell J; Lundstedt D; Olofsson Bagge R; Rydén L; Sund M; SENOMAC Trialists’ Group
Article: BREAST CANCER RESEARCH AND TREATMENT. 2019;177(2):469-475

Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer.

Andersson Y; Bergkvist L; Frisell J; de Boniface J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2019;174(3):795-805

Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant.

Robertson S; Rönnlund C; de Boniface J; Hartman J
Article: BRITISH JOURNAL OF SURGERY. 2018;105(12):1607-1614

Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation.

de Boniface J; Frisell J; Bergkvist L; Andersson Y
Article: BREAST CANCER RESEARCH AND TREATMENT. 2018;171(2):359-369

Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.

Andersson Y; Bergkvist L; Frisell J; de Boniface J
Journal article: EUROPEAN JOURNAL OF CANCER. 2018;92:s68

254 (PB-049) Risk of recurrence and death in breast cancer patients after delayed deep inferior epigastric perforator flap reconstruction

Adam H; Skogh ACD; Nord AE; Schultz I; Gahm J; Hall P; Frisell J; Halle M; De Boniface J
Article: BMC CANCER. 2017;17(1):379

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

de Boniface J; Frisell J; Andersson Y; Bergkvist L; Ahlgren J; Rydén L; Olofsson Bagge R; Sund M; Johansson H; Lundstedt D; SENOMAC Trialists’ Group
Article: BREAST CANCER RESEARCH AND TREATMENT. 2017;163(1):103-110

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.

Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
Article: BREAST CANCER RESEARCH AND TREATMENT. 2017;163(1):93-101

Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.

Zetterlund L; Celebioglu F; Axelsson R; de Boniface J; Frisell J
Article: LAKARTIDNINGEN. 2017;114:EECT

[Oncoplastic surgery – distinctively personalized].

de Boniface J; Lagergren J
Article: BRITISH JOURNAL OF SURGERY. 2017;104(3):238-247

Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study.

de Boniface J; Frisell J; Bergkvist L; Andersson Y; Swedish Breast Cancer Group and the Swedish Societ
Article: BREAST. 2016;30:32-38

Impact of previous surgery on sentinel lymph node mapping: Hybrid SPECT/CT before and after a unilateral diagnostic breast excision.

Zetterlund L; Gabrielson S; Axelsson R; de Boniface J; Frisell J; Olsson A; Celebioglu F
Article: BRITISH JOURNAL OF SURGERY. 2016;103(12):1640-1648

National study of the impact of patient information and involvement in decision-making on immediate breast reconstruction rates.

Frisell A; Lagergren J; de Boniface J
Journal article: EJSO. 2016;42(9):s101-s102

85. Sentinel node biopsy before neoadjuvant chemotherapy in breast cancer: A Swedish multicenter study

Zetterlund L; Axelsson R; De Boniface J; Frisell J; Celebioglu F
Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2016;14(1):227

Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer.

Miyan M; Schmidt-Mende J; Kiessling R; Poschke I; de Boniface J
Article: EJSO. 2014;40(10):1209-1215

The oncological safety of nipple-sparing mastectomy - a Swedish matched cohort study.

Adam H; Bygdeson M; de Boniface J
Article: BRITISH JOURNAL OF CANCER. 2014;111(5):918-926

Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis.

Rosin G; de Boniface J; Karthik GM; Frisell J; Bergh J; Hartman J
Article: BRITISH JOURNAL OF SURGERY. 2014;101(5):488-494

Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinoma in situ.

Zetterlund L; Stemme S; Arnrup H; de Boniface J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2013;142(3):591-601

Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohort.

Eriksson M; Anveden L; Celebioglu F; Dahlberg K; Meldahl I; Lagergren J; Eriksen C; de Boniface J
Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2013;11:290

Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes.

Poschke I; Mao Y; Kiessling R; de Boniface J
Article: BRITISH JOURNAL OF SURGERY. 2013;100(6):775-783

Causes of false-negative sentinel node biopsy in patients with breast cancer.

Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
Article: PLOS ONE. 2013;8(2):e56795

High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes.

Taher C; de Boniface J; Mohammad A-A; Religa P; Hartman J; Yaiw K-C; Frisell J; Rahbar A; Söderberg-Naucler C
Article: ONCOIMMUNOLOGY. 2012;1(8):1305-1312

Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients.

de Boniface J; Mao Y; Schmidt-Mende J; Kiessling R; Poschke I
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(7):1611-1620

Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients.

Poschke I; De Boniface J; Mao Y; Kiessling R
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(1):129-139

Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function.

Boniface JD; Poschke I; Mao Y; Kiessling R
Article: BRITISH JOURNAL OF SURGERY. 2012;99(2):226-231

Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer.

Andersson Y; de Boniface J; Jönsson P-E; Ingvar C; Liljegren G; Bergkvist L; Frisell J; Swedish Breast Cancer Group; Swedish Society of Breast Surgeons
Article: BREAST CANCER: BASIC AND CLINICAL RESEARCH. 2012;6:bcbcr.s8642-38

Prediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases: evaluation of the tenon score.

Andersson Y; Frisell J; de Boniface J; Bergkvist L
Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(17):2868-2873

Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.

Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
Article: ANNALS OF SURGERY. 2008;247(1):150-156

Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.

Bergkvist L; de Boniface J; Jönsson P-E; Ingvar C; Liljegren G; Frisell J; Swedish Society of Breast Surgeons
Article: BRITISH JOURNAL OF SURGERY. 2007;94(8):948-951

Sentinel node biopsy for breast cancer larger than 3 cm in diameter.

Schüle J; Frisell J; Ingvar C; Bergkvist L
Article: BREAST CANCER RESEARCH AND TREATMENT. 2002;74(1):33-40

Down-regulation of the CD3-zeta chain in sentinel node biopsies from breast cancer patients.

Schüle J; Bergkvist L; Håkansson L; Gustafsson B; Håkansson A
Visa fler

Alla övriga publikationer

Review: ECLINICALMEDICINE. 2023;61:102085

The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus.

Kaidar-Person O; Pfob A; Gentilini OD; Borisch B; Bosch A; Cardoso MJ; Curigliano G; De Boniface J; Denkert C; Hauser N; Heil J; Knauer M; Kühn T; Lee H-B; Loibl S; Mannhart M; Meattini I; Montagna G; Pinker K; Poulakaki F; Rubio IT; Sager P; Steyerova P; Tausch C; Tramm T; Vrancken Peeters M-J; Wyld L; Yu JH; Weber WP; Poortmans P; Dubsky P
Review: SCANDINAVIAN JOURNAL OF SURGERY. 2023;112(2):117-125

Axillary staging in node-positive breast cancer converting to node negativity through neoadjuvant chemotherapy: Current evidence and perspectives.

Banys-Paluchowski M; de Boniface J
Review: CANCER TREATMENT REVIEWS. 2023;117:102556

Uncertainties and controversies in axillary management of patients with breast cancer.

Weber WP; Davide Gentilini O; Morrow M; Montagna G; de Boniface J; Fitzal F; Wyld L; Rubio IT; Matrai Z; King TA; Saccilotto R; Galimberti V; Maggi N; Andreozzi M; Sacchini V; Castrezana López L; Loesch J; Schwab FD; Eller R; Heidinger M; Haug M; Kurzeder C; Di Micco R; Banys-Paluchowski M; Ditsch N; Harder Y; Paulinelli RR; Urban C; Benson J; Bjelic-Radisic V; Potter S; Knauer M; Thill M; Vrancken Peeters M-J; Kuemmel S; Heil J; Gulluoglu BM; Tausch C; Ganz-Blaettler U; Shaw J; Dubsky P; Poortmans P; Kaidar-Person O; Kühn T; Gnant M
Review: EUROPEAN JOURNAL OF CANCER. 2023;181:79-91

EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.

Schmidt MK; Kelly JE; Brédart A; Cameron DA; de Boniface J; Easton DF; Offersen BV; Poulakaki F; Rubio IT; Sardanelli F; Schmutzler R; Spanic T; Weigelt B; Rutgers EJT
Review: CANCERS. 2023;15(4):1173

Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).

Banys-Paluchowski M; Kühn T; Masannat Y; Rubio I; de Boniface J; Ditsch N; Karadeniz Cakmak G; Karakatsanis A; Dave R; Hahn M; Potter S; Kothari A; Gentilini OD; Gulluoglu BM; Lux MP; Smidt M; Weber WP; Aktas Sezen B; Krawczyk N; Hartmann S; Di Micco R; Nietz S; Malherbe F; Cabioglu N; Canturk NZ; Gasparri ML; Murawa D; Harvey J
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)

MELODY (Methods for Localization of Different Types of Breast Lesions): A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET)

Banys-Paluchowski M; Kuhn T; Masannat Y; Rubio IT; de Boniface J; Ditsch N; Karakatsanis A; Dave RV; Potter S; Kothari A; Gentilini OD; Weber WP; Krawczyk N; Hartmann S; Cakmak GK; Hahn M; Lux MP; Smidt M; Cabioglu N; Harvey J
Conference publication: BREAST. 2023;68:S7-S8

Axillary surgery in the adjuvant setting

de Boniface J
Conference publication: GEBURTSHILFE UND FRAUENHEILKUNDE. 2022;82(6):S47-S48

AXSANA - AXillary Surgery After NeoAdjuvant Treatment: A prospective, multicenter Cohort Study by the EUBREAST Study Group to evaluate different surgical Procedures of axillary Staging in initially node-positive Patients after neoadjuvant Chemotherapy

Rief A; Kuehn T; Peintinger F; Hartmann S; Stickeler E; de Boniface J; Gentilini O; Ruf F; Froehlich S; Thill M; Hauptmann M; Berger T; Wihlfahrt K; Cakmak KG; Rubio TI; Gasparri LM; Kontos M; Bonci E-A; Niinikoski L; Murawa D; Appelgren M; Hahn M; Pristauz-Telsnigg G; Czihak J; Banys-Paluchowski M
Conference publication: SENOLOGIE - ZEITSCHRIFT FÜR MAMMADIAGNOSTIK UND -THERAPIE. 2022;19(02):e15

AXSANA – AXillary Surgery After NeoAdjuvant Treatment (EUBREAST-3): current status of the international prospective multicenter cohort study evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Fröhlich S; Hartmann S; Banys-Paluchowski M; Stickeler E; de Boniface J; Gentilini O; Ruf F; Thill M; Hauptmann M; Rief A; Berger T; Wihlfahrt K; Cakmak GK; Rubio I; Gaspari ML; Kontos M; Bonci E-A; Niinikoski L; Murawa D; Pinto D; Peintinger F; Schlichting E; Krivorotko P; Vasquez LR; Valiyeva H; Helidon N; Appelgren M; Hahn M; Thiemann E; Kaltenecker G; Kühn T
Conference publication: ANNALS OF ONCOLOGY. 2022;33:S178-S179

AXSANA (AXillary Surgery After NeoAdjuvant Treatment) EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Ruf F; Kuehn T; Hartmann S; de Boniface J; Gentilini OD; Stickeler E; Cakmak GK; Rubio I; Niinikoski L; Kontos M; Murawa D; Bonci E-A; Hauptmann M; Thill M; Markus H; Lux MP; Appelgren M; Blohmer J-U; Untch M; Banys-Paluchowski M
Conference publication: CANCER RESEARCH. 2022;82(4):p1-01-16-p1-01-16

Perspectives on axillary management after primary systemic treatment: An international EUBREAST survey

Gasparri ML; De Boniface J; Gentilini OD; Kaidar-Person O; Poortmans P; Kuehn T
Conference publication: CANCER RESEARCH. 2022;82(4):ot1-04-04-ot1-04-04

AXSANA - EUBREAST 3 (axillary surgery after neoadjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Kuhn T; Hartmann S; Stickeler E; de Boniface J; Gentilini O; Frohlich S; Ruf F; Thill M; Hauptmann M; Cakmak GK; Rubio I; Gasparri ML; Kontos M; Bonci E-A; Niinikoski L; Di Micco R; Murawa D; Pinto D; Peintinger F; Solbach C; Appelgren M; Blohmer J-U; Weigel M; Kaltenecker G; Schrauder M; Simons J; Smidt M; Schlichting E; Dostalek L; Emelyanov AS; Thiemann E; Gunay S; Loibl S; Banys-Paluchowski M
Editorial comment: ANNALS OF SURGICAL ONCOLOGY. 2022;29(2):1073-1075

ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study

Fitzal F; Bolliger M; Dunkler D; Geroldinger A; Gambone L; Heil J; Riedel F; de Boniface J; Andre C; Matrai Z; Pukancsik D; Paulinelli RR; Ostapenko V; Burneckis A; Ostapenko A; Ostapenko E; Meani F; Harder Y; Bonollo M; Alberti ASM; Tausch C; Papassotiropoulos B; Helfgott R; Heck D; Fehrer H-J; Acko M; Schrenk P; Trapp E; Gunda P-T; Clara P; Montagna G; Ritter M; Blohmer J-U; Steffen S; Romics L; Morrow E; Lorenz K; Fehr M; Weber WP
Letter: JAMA SURGERY. 2022;157(2):174-175

Eradication of Potential In-Transit Metastasis in Breast-Conserving Surgery-Reply.

de Boniface J; Szulkin R; Johansson ALV
Conference publication: ONCOLOGY RESEARCH AND TREATMENT. 2022;45(SUPPL 3):24-25

AXSANA - EUBREAST 3 (AXillary Surgery After NeoAdjuvant Treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Banys-Paluchowski M; Hartmann S; Stickeler E; De Boniface J; Gentilini O; Froehlich S; Thill M; Ruf F; Hauptmann M; Cakmak GK; Rubio IT; Gasparri ML; Kontos M; Bonci E-A; Niinikoski L; Di Micco R; Murawa D; Pinto D; Peintinger F; Dostalek L; Solbach C; Appelgren M; Blohmer J-U; Thiemann E; Weigel M; Kaltenecker G; Ramaker K; Schrauder MG; Kuehn T
Review: GEBURTSHILFE UND FRAUENHEILKUNDE. 2021;81(10):1121-1127

Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy.

Hartmann S; Stachs A; Kühn T; de Boniface J; Banys-Paluchowski M; Reimer T
Conference publication: SENOLOGIE - ZEITSCHRIFT FÜR MAMMADIAGNOSTIK UND -THERAPIE. 2021;18(02):e2

AXSANA (Axillary Surgery After Neoadjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy: preliminary data

Banys-Paluchowski M; Hartmann S; Stickeler E; de Boniface J; Gentilini O; Fröhlich S; Thill M; Hauptmann M; Karadeniz CG; Rubio I; Gasparri M; Kontos M; Bonci E; Niinikoski L; Di Micco R; Murawa D; Pinto D; Peintinger F; Solbach C; Appelgren M; Blohmer J; Weigel M; Kaltenecker G; Schrauder; Kühn T
Review: CANCERS. 2021;13(7):1565

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.

Banys-Paluchowski M; Gasparri ML; de Boniface J; Gentilini O; Stickeler E; Hartmann S; Thill M; Rubio IT; Di Micco R; Bonci E-A; Niinikoski L; Kontos M; Karadeniz Cakmak G; Hauptmann M; Peintinger F; Pinto D; Matrai Z; Murawa D; Kadayaprath G; Dostalek L; Nina H; Krivorotko P; Classe J-M; Schlichting E; Appelgren M; Paluchowski P; Solbach C; Blohmer J-U; Kühn T; The Axsana Study Group
Conference publication: BREAST. 2021;56:S71-S72

Retrospective multicenter analysis comparing conventional with oncoplastic breast conservation: oncologic and surgical outcome in women with high risk breast cancer from the OPBC-01/iTOP2 study

Fitzal F; Bolliger M; Dunkler D; Gambone L; Heil J; Riedel F; de Boniface J; Andre C; Matrai Z; Pukancsik D; Paulinelli RR; Ostapenko V; Burneckis A; Ostapenko A; Ostapenko E; Meani F; Harder Y; Bonollo M; Alberti ASM; Tausch C; Papassotiropoulos B; Helfgott R; Heck D; Fehrer HJ; Acko M; Schrenk P; Montagna G; Trapp E; Pristauz G; Paliczek C; Blohmer JU; Steffen S; Romics L; Morrow E; Lorenz K; Fehr M; Ritter M; Weber WP
Conference publication: CANCER RESEARCH. 2021;81(4)

Pre- versus sub-pectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02 PREPEC): A pragmatic, multicenter, randomized, superiority trial

Weber WP; Kappos EA; Regan MM; Moffa G; Harder Y; Ribi K; Potter S; Pusic A; Fehr MK; Hemkens LG; Holzbach T; Farhadi J; Simonson C; Knauer M; Verstappen R; Bucher H; Zwahlen D; Zimmermann F; Schwenkglenks M; Mucklow R; Bjelic-Radisic V; Chiorescu A; Chun Y; Farah S; Chen X; Nigard L; Kummel S; Reitsamer R; Hauschild M; Fulco I; Tausch C; Fischer T; Sarlos D; Constantinescu M; Lupatsch JE; Fitzal F; Heil J; Matrai Z; de Boniface J; Kurzeder C; Haug M; Schulz A
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2021;161:S42-S43

Quality assessment of locoregional breast cancer radiotherapy in the international SENOMAC-trial

Alkner S; Lundstedt D; Wieslander E; Berg M; Kristensen I; Ahlgren J; Offersen B; de Boniface J; Dahl Nissen H
Conference publication: CANCER RESEARCH. 2021;81(4)

The AXSANA trial (AXillary Surgery After NeoAdjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Banys-Paluchowski M; Stickeler E; de Boniface J; Gentilini O; Thill M; Hartmann S; Mangold M; Solbach C; Blohmer J-U; Untch M; Appelgren M; Kolberg H-C; Kuhn T
Conference publication: BREAST. 2021;56:S69

Survival after breast conservation versus mastectomy adjusted for comorbidity and socioeconomic status: national 6-year follow-up on 48986 women

de Boniface J; Szulkin R; Johansson A
Conference publication: GEBURTSHILFE UND FRAUENHEILKUNDE. 2020;80(10):E93-E94

AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

Banys-Paluchowski M; Stickeler E; de Boniface J; Gentilini O; Thill M; Hartmann S; Fasching PA; Huebner H; Krawczyk N; Blohmer JU; Solbach C; Untch M; T K
Conference publication: GEBURTSHILFE UND FRAUENHEILKUNDE. 2020;80(10):E112

Target Lymph Node Biopsy (TLNB) after Carbon Labeling in Breast Cancer Patients as part of primary System Therapy - Results of the TATTOO Study

Hartmann S; Stachs A; Kuehn T; Winckelmann A; de Boniface J; Gerber B; Reimer T
Review: LANCET ONCOLOGY. 2020;21(8):e375-e385

Knowledge gaps in oncoplastic breast surgery.

Weber WP; Morrow M; Boniface JD; Pusic A; Montagna G; Kappos EA; Ritter M; Haug M; Kurzeder C; Saccilotto R; Schulz A; Benson J; Fitzal F; Matrai Z; Shaw J; Peeters M-JV; Potter S; Heil J; Oncoplastic Breast Consortium
Conference publication: GEBURTSHILFE UND FRAUENHEILKUNDE. 2020;80(06):E20-E21

AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

Banys-Paluchowski M; Stickeler E; de Boniface J; Gentilini O; Thill M; Hartmann S; Fasching PA; Huebner H; Krawczyk N; Blohmer J-U; Solbach C; Untch M; Kuehn T
Conference publication: GEBURTSHILFE UND FRAUENHEILKUNDE. 2020;80(06):E36

TLNB (Target Lymph Node Biopsy) after Carbon Labeling in Breast Cancer Patients after primary System Therapy Results of the TATTOO Study

Hartmann S; Stachs A; Kuehn T; Winckelmann A; de Boniface J; Gerber B; Reimer T
Conference publication: SENOLOGIE - ZEITSCHRIFT FÜR MAMMADIAGNOSTIK UND -THERAPIE. 2020;17(02):e2

AXSANA (AXillary Surgery After NeoAdjuvant Treatment): A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy

Banys-Paluchowski M; Stickeler E; de Boniface J; Gentilini O; Thill M; Hartmann S; Fasching P; Huebner H; Krawczyk N; Blohmer J-U; Solbach C; Untch M; Kühn T
Conference publication: SENOLOGIE - ZEITSCHRIFT FÜR MAMMADIAGNOSTIK UND -THERAPIE. 2020;17(02):e17-e18

TLNB (Target-Lymph-Node-Biopsy) nach Kohlenstoffmarkierung bei Mammakarzinom-Patientinnen nach primärer Systemtherapie Ergebnisse der TATTOO-Studie

Hartmann S; Stachs A; Kühn T; Winckelmann A; de Boniface J; Gerber B; Reimer T
Editorial comment: BREAST CARE. 2020;15(2):188-191

Immediate Breast Reconstruction.

Kappos EA; Weber WP; de Boniface J; Harder Y; Heil J; Fitzal F; Matrai Z
Conference publication: CANCER RESEARCH. 2020;80(4):ot3-01-01-ot3-01-01

Feasibility of carbon tattooing for targeted lymph node biopsy in breast cancer patients treated by primary systemic therapy (TATTOO trial)

Hartmann S; Stachs A; Kuhn T; Winckelmann A; de Boniface J; Gerber B; Reimer T
Review: CURRENT OPINION IN OBSTETRICS & GYNECOLOGY. 2020;32(1):91-99

Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019.

Ditsch N; Rubio IT; Gasparri ML; de Boniface J; Kuehn T
Conference publication: EUROPEAN JOURNAL OF CANCER. 2020;138:S36

Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer

Andersson Y; Frisell J; Bergkvist L; de Boniface J
Conference publication: EUROPEAN JOURNAL OF CANCER. 2020;138:S22

Long-term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

Zetterlund L; Celebioglu F; Frisell J; de Boniface J
Conference publication: EUROPEAN JOURNAL OF CANCER. 2020;138:S3

Omitting completion axillary lymph node dissection after sentinel node micrometastases in breast cancer - first results from the Swedish prospective SENOMIC trial

Andersson Y; Bergkvist L; Frisell J; de Boniface J
Conference publication: EUROPEAN JOURNAL OF CANCER. 2020;138:S3

The generalisability of randomised clinical trials: An interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer

De Boniface J; Ahlgren J; Andersson Y; Bergkvist L; Frisell J; Lundstedt D; Bagge RO; Ryden L; Sund M
Conference publication: EUROPEAN JOURNAL OF CANCER. 2020;138:S95

Breast cancer patients undergoing delayed deep inferior epigastric perforator (DIEP) flap reconstruction differ from their matched controls by a higher socioeconomic status and better overall survival

Adam H; Skogh ACD; Frisell J; De Boniface J
Conference publication: EUROPEAN JOURNAL OF CANCER. 2020;138:S28-S29

Oncoplastic breast-conserving surgery offers low local recurrence rates and excellent survival rates despite worse tumor characteristics

Andre C; Holsti C; Svenner A; Oikonomou I; Sackey HI; Appelgren M; Johansson A; de Boniface J
Preprint: SSRN ELECTRONIC JOURNAL. 2020

Superior Survival After Breast Conservation Versus Mastectomy Despite Adjustment for Comorbidity and Socioeconomic Status: Median Follow-Up of Six Years on 48986 Breast Cancer Patients From Swedish National Registers

de Boniface J; Szulkin R; Johansson A
Letter: LANCET ONCOLOGY. 2019;20(1):e1

A gap analysis of opportunities and priorities for breast surgical research.

Gentilini OD; De Boniface J; Classe J-M; Peintinger F; Reimer T; Reitsamer R; Rubio I; Smidt M; Kuehn T
Review: BREAST CANCER RESEARCH AND TREATMENT. 2018;172(3):523-537

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy.

Weber WP; Haug M; Kurzeder C; Bjelic-Radisic V; Koller R; Reitsamer R; Fitzal F; Biazus J; Brenelli F; Urban C; Paulinelli RR; Blohmer J-U; Heil J; Hoffmann J; Matrai Z; Catanuto G; Galimberti V; Gentilini O; Barry M; Hadar T; Allweis TM; Olsha O; Cardoso MJ; Gouveia PF; Rubio IT; de Boniface J; Svensjö T; Bucher S; Dubsky P; Farhadi J; Fehr MK; Fulco I; Ganz-Blättler U; Günthert A; Harder Y; Hauser N; Kappos EA; Knauer M; Landin J; Mechera R; Meani F; Montagna G; Ritter M; Saccilotto R; Schwab FD; Steffens D; Tausch C; Zeindler J; Soysal SD; Lohsiriwat V; Kovacs T; Tansley A; Wyld L; Romics L; El-Tamer M; Pusic AL; Sacchini V; Gnant M
Review: BREAST CARE. 2018;13(5):337-341

Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting.

Kühn T; Classe J-M; Gentilini OD; Tinterri C; Peintinger F; de Boniface J
Review: BREAST CARE. 2018;13(5):331-336

What Is the Best Management of cN0pN1(sn) Breast Cancer Patients?

de Boniface J; Schmidt M; Engel J; Smidt ML; Offersen BV; Reimer T
Published conference paper: BRITISH JOURNAL OF SURGERY. 2018;105(11):1435-1445

Risk of recurrence and death in patients with breast cancer after delayed deep inferior epigastric perforator flap reconstruction.

Adam H; Docherty Skogh AC; Edsander Nord Å; Schultz I; Gahm J; Hall P; Frisell J; Halle M; de Boniface J
Conference publication: CANCER RESEARCH. 2018;78(4_Supplement):p4-13-14-p4-13-14

Abstract P4-13-14: Risk of recurrence and death in breast cancer patients after delayed deep inferior epigastric perforator flap reconstruction

Adam H; Docherty Skogh A-C; Edsander Nord Å; Schultz I; Gahm J; Hall P; Frisell J; Halle M; de Boniface J
Conference publication: EUROPEAN JOURNAL OF CANCER. 2018;92:S68

Risk of recurrence and death in breast cancer patients after delayed deep inferior epigastric perforator flap reconstruction

Adam H; Skogh ACD; Nord AE; Schultz I; Gahm J; Hall P; Frisell J; Halle M; De Boniface J
Conference publication: CANCER RESEARCH. 2018;78(4)

Risk of recurrence and death in breast cancer patients after delayed deep inferior epigastric perforator flap reconstruction

Adam H; Skogh A-CD; Nord AE; Schultz I; Gahm J; Hall P; Frisell J; Halle M; de Boniface J
Conference publication: VIRCHOWS ARCHIV. 2018;473:S199

Routine biomarkers in preoperative biopsy and resected breast tumour - need for reassessment?

Ronnlund C; Robertson S; de Boniface J; Hartman J
Book chapter: BREAST CANCER MANAGEMENT FOR SURGEONS. 2018;p. 355-364

Breast Implants: Design, Safety and Indications for Use

de Boniface J; Schultz I
Letter: BRITISH JOURNAL OF SURGERY. 2013;100(10):1399

Authors' reply: causes of false-negative sentinel node biopsy in patients with breast cancer (Br J Surg 2013; 100: 775-783).

de Boniface J; Andersson Y
Visa fler

Forskningsbidrag

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection – the randomized SENOMAC trial

Swedish Research Council

1 January 2022 - 31 December 2025
Physical exercise during neoadjuvant chemotherapy for breast cancer as a means to increase pathological complete response rates: the randomized Neo-ACT trial

Swedish Research Council

1 December 2021 - 30 November 2025
Pre- versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipplesparing mastectomy (OPBC-02/ PREPEC): A pragmatic, multicenter, randomized, superiority trial

Swiss National Science Foundation

1 August 2019 - 31 July 2025
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection – the randomized controlled SENOMAC trial.

Swedish Cancer Society

1 January 2019
Do you need to evacuate several lymph nodes from the armpit at early breast cancer with microscopic spread to sentinel node (the porter gland)?

Swedish Cancer Society

1 January 2017
Do you need to evacuate several lymph nodes from the armpit at early breast cancer with microscopic spread to sentinel node (the porter gland)?

Swedish Cancer Society

1 January 2016
Do you need to evacuate several lymph nodes from the armpit at early breast cancer with microscopic spread to sentinel node (the porter gland)?

Swedish Cancer Society

1 January 2015
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection – the randomized SENOMAC trial.

Swedish Research Council

1 January 2015 - 31 December 2017

Anställningar

Adjungerad Professor, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2024-2028

Examina och utbildning

Docent, kirurgi, Karolinska Institutet, 2014

Om mig

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI